Advertisement

The Tonsillar Fossa Battleground

      A 57-year-old man with a remote 4-pack-year history of cigarette smoking recently experienced globus sensation and intermittent left ear pain, simultaneous with a 10 pound weight loss he had initiated for “personal health reasons.”
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article

      • Clinical Trial or Unilateral RT with Cisplatin
        International Journal of Radiation Oncology • Biology • PhysicsVol. 97Issue 1
        • Preview
          The patient (1) has a T2N2bM0 AJCC Stage IVA, HPV(+) squamous cell cancer of the left tonsil. Despite the 7th edition stage designation, this patient has relatively low bulk disease. A multidisciplinary setting would be the best way to evaluate any patient in this situation
        • Full-Text
        • PDF
      • Try to Avoid Tri-Modality Treatment
        International Journal of Radiation Oncology • Biology • PhysicsVol. 97Issue 1
      • Robotic Surgery plus Chemo-Radiation Therapy
        International Journal of Radiation Oncology • Biology • PhysicsVol. 97Issue 1
        • Preview
          We present these cases to our multidisciplinary team which includes medical oncology, radiation oncology, and head and neck surgery to establish the best possible therapy options for this patient (1). For this discussion we will assume a remote tobacco history and no significant comorbidities.
        • Full-Text
        • PDF
      • Surgery plus PORT
        International Journal of Radiation Oncology • Biology • PhysicsVol. 97Issue 1
        • Preview
          This patient (1) has a low-risk HPV-associated oropharyngeal carcinoma (HPV+OPC) with a 3-year survival >90% following treatment (2). Due to this excellent prognosis, and morbidity associated with current treatment paradigms, these patients remain the subject of de-escalation trials, with no universal consensus on optimal treatment.
        • Full-Text
        • PDF
      • Transoral Robotic Surgery and the Standard of Care
        International Journal of Radiation Oncology • Biology • PhysicsVol. 97Issue 1

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.